Search

Your search keyword '"Harrison, Christine J"' showing total 986 results

Search Constraints

Start Over You searched for: Author "Harrison, Christine J" Remove constraint Author: "Harrison, Christine J"
986 results on '"Harrison, Christine J"'

Search Results

1. Acute lymphoblastic leukaemia

2. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

3. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748

4. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia

6. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial

8. Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia

9. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group

10. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21

11. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia

12. Genetic characterization and therapeutic targeting of MYC‐rearranged T cell acute lymphoblastic leukaemia

13. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia

14. hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia

15. Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study

17. Pelops: A dedicated caller for DUX4 rearrangements from whole-genome sequencing data

20. Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group

22. Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

23. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia

27. Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL

35. Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group

36. Measurable residual disease and fusion partner independently predict survival and relapse risk in childhood KMT2A-rearranged acute myeloid leukemia : a study by the international Berlin-Frankfurt-Münster study group

37. Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia:A Study by the International Berlin-Frankfurt-Munster Study Group

38. Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/ KMT2A Rearrangements in a Modern Therapy Era:A Retrospective International Study

39. Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement

40. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

42. Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia

48. Cytogenetics

49. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial

50. Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial

Catalog

Books, media, physical & digital resources